期刊文献+

结缔组织病伴间质性肺疾病的治疗研究 被引量:2

MANAGEMENT OF INTERSTITIAL LUNG DISEASES COMPLICATED BY CONNECTIVE TISSUE DISEASES
下载PDF
导出
摘要 目的 对结缔组织病 (CTD)伴间质性肺疾病 (ILD)患者进行治疗研究。方法  13例CTD伴ILD患者治疗半年后复查。结果  12例患者血沉 (ESR)下降 ,肺功能、一氧化碳弥散量 (DLCO)、PO2 有明显改善 ,且P <0 .0 5。胸片检查 :1例毛玻璃样改变和 1例斑片网格状阴影基本消失。 1例网格状阴影形成蜂窝状影。HRCT检查 :9例毛玻璃样改变中 ,7例有改善 ,2例形成索条蜂窝样改变 ;2例胸膜下结节和 2例胸膜边缘不规则消失 ;3例小叶间隔增厚消失。其余的网状、索条、蜂窝状和肺大泡基本无改变。 1例SLE患者因合并肺部感染而死亡。结论 对急性ILD早期强的松或强的松加免疫抑制剂治疗 ,对慢性ILD可不予特别治疗。对ILD合并肺部感染者 ,要严格掌握激素用量 。 Objective\ In order to study the treatment of the connective tissue diseases (CTD)with complication the interstital lung diseases(ILD). Methods\ Thirteen non-smoking CTD with complication ILD patients were re-examined after 6 months treatment period. Results\ Treatment results revealed changed in ESR and pulmonary function tests(PFT), it had significantly different (P<0.05),and improved in chest X-ray examination in twelve patients. In nine patients of the grond-glass appearance of high-resolution computed tomography(HRCT), had obvious improved in seven patients and had changed the honeycombing appearance in two patients. Interlobular septal thickening of three patients and subpleural nodules of two patients and irregular pleural margins of two patients had obvious improved. Other appearance of HRCT revealed unchanged for and reticulation and honeycombing and emphysema.One SLE with compli\|cation ILD patient had died for combining pulmonary infection. Conclusion\ Acute ILD should been early treated with prednisone or prednisone and immunosuppressor. Clinical ILD were not been especially treated. The dose of prednisone were been strict mastered and synthesize treatment were been used for ILD with pulmonary infection.
作者 陆亚华
出处 《医师进修杂志》 北大核心 2002年第1期25-27,共3页 Journal of Postgraduates of Medicine
关键词 结缔组织病 间质性肺疾病 强的松 免疫抑制剂 治疗 connective tissue disease interstitial lung disease prednisone immunosuppressor treatment
  • 相关文献

参考文献5

二级参考文献2

  • 1刘菱芬 李玉瑞.胶原蛋白合成的测定.细胞外基质的研究方法[M].北京:人民卫生出版社,1988.196-225.
  • 2刘菱芬,细胞外间质的生物化学及研究方法,1988年,196页

共引文献136

同被引文献14

  • 1特发性肺纤维化诊断及治疗(试行方案)[J].中华结核和呼吸杂志,1994,17(1):8-8. 被引量:103
  • 2胥韦,李羲.特发性肺纤维化诊断进展[J].医学综述,2006,12(16):977-979. 被引量:3
  • 3Coultas DB,Zumwalt RE,Black WC,et al.The epidemiology of interstitial lung dieas.Am J Respir Crit Care Med,1994;150(4):967.
  • 4Wells AU,King AD,Rubens MB,et al.Lone cryptogenic fibrosing alveolitis:a fimctional-morphologic correlation based on extent of disease on thin-soction computed tomography.Am J Resp ir Crit Care Med,1997;155(4):1367.
  • 5A wangyongliang,A gusti C,Luburich P,et al.pulmonary function tests and CT scan in the mangement of idiopathic pulmonary fibrosis.Am J Respir Crit Care Med,1998;158(2):431.
  • 6Terrif BA,Kwan MM,Chan Young,et al.Fibrosing alveolitis:chest radiography and CT as predictors of clinical and functional impairment at follow-up in 26patients.Radiology,1992;184(2):445.
  • 7Katzenstein AL,Myers JL.Idiopathic pulmonary fibrosis:clinical rele-vance of pathologic classification.Am J Respir Crit Care Med,1998;157(4Ptl):1301-1315.
  • 8罗炎杰 袁玉如 见:陈文彬 程德云主编.临床常用肺功能测定[A].见:陈文彬,程德云主编.呼吸系统疾病诊疗技术[C].北京:人民卫生出版社,2000.29-51.
  • 9American Thoracic Society,European Respiratory Society. American Thoracic Society/European Respiratory Society International MultidiscipLinary Consensus Classification of the idiopathic interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS)was adopted by ATS board of directors,June 2001 and by the ERS Executive Committee,June 2001. Am J Respir Crit Care Med,2002,165 (2): 277-304.
  • 10Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med, 1998,157(4Ptl ) : 1301-1315.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部